Dr Sarah Mason

Interests

My research interests are:

1) Better defining the neuropsychological profile of presymptomatic and early Huntington's disease using fMRI scanning and behavioural testing. With a particular interest in determining the factors which underpin the cognitive heterogeneity of the disease.

2) Understanding the role of apathy in Huntington's disease, how it evolves with advancing disease and its relationship to cognitive processes such as reward processing, decision making and emotional.

3) Exploring social cognition in Huntington's disease.

Research Focus

Keywords

Emotion

Social cognition

Apathy

Dementia

fMRI

Clinical conditions

Huntington's disease

Parkinson's disease

Equipment

fMRI

Neuropsychological testing

Collaborators

Cambridge

Roger Barker

United Kingdom

Adam Hampshire

Associated News Items


    Publications

    2014

    Barker RA, Mason SL (2014), “Neurodegenerative disease: Mapping the natural history of Huntington disease.” Nat Rev Neurol 10(1):12-3 Details

    2013

    Barker RA, Barrett J, Mason SL, Bj√∂rklund A (2013), “Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease.” Lancet Neurol 12(1):84-91 Details

    Barker RA, Mason SL, Harrower TP, Swain RA, Ho AK, Sahakian BJ, Mathur R, Elneil S, Thornton S, Hurrelbrink C, Armstrong RJ, Tyers P, Smith E, Carpenter A, Piccini P, Tai YF, Brooks DJ, Pavese N, Watts C, Pickard JD, Rosser AE, Dunnett SB, NEST-UK collaboration (2013), “The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease.” J Neurol Neurosurg Psychiatry 84(6):657-65 Details

    Begeti F, Tan AY, Cummins GA, Collins LM, Guzman NV, Mason SL, Barker RA (2013), “The Addenbrooke's Cognitive Examination-Revised accurately detects cognitive decline in Huntington's disease.” J Neurol 260(11):2777-85 Details

    Breen DP, Williams-Gray CH, Mason SL, Foltynie T, Barker RA (2013), “Excessive daytime sleepiness and its risk factors in incident Parkinson's disease.” J Neurol Neurosurg Psychiatry 84(2):233-4 Details

    Williams-Gray CH, Mason SL, Evans JR, Foltynie T, Brayne C, Robbins TW, Barker RA (2013), “The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort.” J Neurol Neurosurg Psychiatry 84(11):1258-64 Details

    Winder-Rhodes SE, Evans JR, Ban M, Mason SL, Williams-Gray CH, Foltynie T, Duran R, Mencacci NE, Sawcer SJ, Barker RA (2013), “Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort.” Brain 136(Pt 2):392-9 Details

    2012

    Evans JR, Mason SL, Barker RA (2012), “Current status of clinical trials of neural transplantation in Parkinson's disease.” Prog Brain Res 200:169-98 Details

    McColgan P, Evans JR, Breen DP, Mason SL, Barker RA, Williams-Gray CH (2012), “Addenbrooke's Cognitive Examination-Revised for mild cognitive impairment in Parkinson's disease.” Mov Disord 27(9):1173-7 Details

    2011

    Barker RA, Mason SL (2011), “Neurodegenerative disease: Tracking disease progress in Huntington disease.” Nat Rev Neurol 7(4):192-3 Details

    Evans JR, Mason SL, Williams-Gray CH, Foltynie T, Brayne C, Robbins TW, Barker RA (2011), “The natural history of treated Parkinson's disease in an incident, community based cohort.” J Neurol Neurosurg Psychiatry Details

    Evans JR, Mason SL, Williams-Gray CH, Foltynie T, Trotter M, Barker RA (2011), “The factor structure of the UPDRS as an index of disease progression in Parkinson's disease.” J Parkinsons Dis 1(1):75-82 Details

    Politis M, Pavese N, Tai YF, Kiferle L, Mason SL, Brooks DJ, Tabrizi SJ, Barker RA, Piccini P (2011), “Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study.” Hum Brain Mapp 32(2):258-70 Details

    2010

    Antoniades CA, Xu Z, Mason SL, Carpenter RH, Barker RA (2010), “Huntington's disease: changes in saccades and hand-tapping over 3¬†years.” J Neurol 257(11):1890-8 Details

    Calder AJ, Keane J, Young AW, Lawrence AD, Mason S, Barker RA (2010), “The relation between anger and different forms of disgust: implications for emotion recognition impairments in Huntington's disease.” Neuropsychologia 48(9):2719-29 Details

    Mason SL, Wijeyekoon R, Swain R, Ho AK, Smith EL, Sahakian B, Barker RA (2010), “Cognitive follow up of a small cohort of Huntington's disease patients over a 5 year period.” PLoS Curr 2 Details

    Pavese N, Politis M, Tai YF, Barker RA, Tabrizi SJ, Mason SL, Brooks DJ, Piccini P (2010), “Cortical dopamine dysfunction in symptomatic and premanifest Huntington's disease gene carriers.” Neurobiol Dis 37(2):356-61 Details

    2009

    Lazic SE, Mason SL, Michell AW, Barker RA (2009), “Visualising disease progression on multiple variables with vector plots and path plots.” BMC Med Res Methodol 9:32 Details

    Mason SL, Barker RA (2009), “Emerging drug therapies in Huntington's disease.” Expert Opin Emerg Drugs 14(2):273-97 Details

    2008

    Reuter I, Tai YF, Pavese N, Chaudhuri KR, Mason S, Polkey CE, Clough C, Brooks DJ, Barker RA, Piccini P (2008), “Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease.” J Neurol Neurosurg Psychiatry 79(8):948-51 Details

    Wedderburn C, Wear H, Brown J, Mason SJ, Barker RA, Hodges J, Williams-Gray C (2008), “The utility of the Cambridge Behavioural Inventory in neurodegenerative disease.” J Neurol Neurosurg Psychiatry 79(5):500-3 Details

    2007

    Antoniades CA, Altham PM, Mason SL, Barker RA, Carpenter R (2007), “Saccadometry: a new tool for evaluating presymptomatic Huntington patients.” Neuroreport 18(11):1133-6 Details